AtriCure, Inc. (ATRC)
40.16
-0.26
(-0.66%)
USD |
NASDAQ |
Dec 30, 16:00
40.16
0.00 (0.00%)
After-Hours: 16:49
AtriCure EPS Diluted (Quarterly): -0.0056 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.9146 |
| Alphatec Holdings, Inc. | -0.1888 |
| Boston Scientific Corp. | 0.5048 |
| iRhythm Technologies, Inc. | -0.162 |
| Perspective Therapeutics, Inc. | -0.3495 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.267M |
| Revenue (Quarterly) | 134.27M |
| Total Expenses (Quarterly) | 134.54M |
| Enterprise Value | 1.945B |
| Gross Profit Margin (Quarterly) | 74.90% |
| Profit Margin (Quarterly) | -0.20% |
| Earnings Yield | -1.51% |
| Normalized Earnings Yield | -0.8877 |